A

Aileron Therapeutics

20 employees

Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs called Stapled Peptides.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Myelopreservation
Chemistry
Chemotherapy
Chemoprotection
Stapled Peptides
Therapeutics
Drug Development
Supportive Care
Biopharma
Biopharmaceuticals

Date founded

2005

Funding rounds raised

Total raised

$40M

from 21 investors over 21 rounds

A

Aileron Therapeutics raised $36M on January 6, 2021

Investors: Lincoln Park Capital, LLC and Acorn Bioventures

A

Aileron Therapeutics raised $33M on October 29, 2014

Investors: ATP (Apple Tree Partners), Lilly Ventures, AJU IB INVESTMENT, S.R. One Ltd and Excel Venture Management, LLC

A

Aileron Therapeutics raised $30M on November 18, 2013

Investors: S.R. One Ltd, Lilly Ventures, Excel Venture Management, LLC and ATP (Apple Tree Partners)

A

Aileron Therapeutics raised $12M on January 14, 2013

Investors: Excel Venture Management, LLC, ATP (Apple Tree Partners), Lilly Ventures and S.R. One Ltd

A

Aileron Therapeutics raised $40M on June 11, 2009

Investors: ATP (Apple Tree Partners), Lilly Ventures, S.R. One Ltd and Excel Venture Management, LLC

A

Aileron Therapeutics raised $7M on June 7, 2007

Investors: ATP (Apple Tree Partners)

A

Aileron Therapeutics raised $7M on December 1, 2006

Investors: ATP (Apple Tree Partners)

FAQ